Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...

Silent Crohn’s disease' is a form of inflammatory bowel disease that may develop without typical or obvious symptoms.

Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- ...

Scientists at the University of Oxford, have identified how rare populations of abnormal cells drive the formation and ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

Tyruko ® (natalizumab-sztn), a biosimilar to Tysabri ® (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

Thanks to COVID-era discussions, the 2023 coverage of a Delta passenger who had diarrhea in their seat (I cannot imagine), ...

By JESSICA N. REX [email protected] This article is part of the “Meet Your Neighbor Monday” series, highlighting the stories of individuals who make Warren County a special place to live. If you ...

NeuroScientific Biopharmaceuticals has reached another clinical milestone, with a fourth Crohn’s disease patient now ...

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells ...

UChicago Medicine has opened the first clinic of its kind in Chicago, and one of only a few nationwide, focused on preconception and pregnancy care for patients with Crohn’s disease and ulcerative ...